GE HealthCare (GEHC)Director bought ~$5M

~$5M

Approx. value · 81K sh @ $61.88

151K

Holds after · shares reported

Traded

May 6, 2026

Filed

May 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately.”
2. Mar 23, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
3. Mar 25, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
4. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
5. Mar 27, 2026CongressDisclosed purchase of GEHC — reported range $1,001 - $15,000
6. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
7. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
8. Apr 30, 2026Insider · 2 peopleInsiders: 2 purchases (~$356K)
9. May 1, 2026Insider · 3 insiders in a week, a first since 2023CFO purchased ~$201K of GEHC shares in the open market
10. May 6, 2026 · this disclosureInsider · 5 insiders in a week, a first since 2023Director purchased ~$5M of GEHC shares in the open market

What came next

1. May 6, 2026Insider · 5 insiders in a week, a first since 2023Director purchased ~$62K of GEHC shares in the open market
2. May 8, 2026Insider · 3 insiders in a week, 2nd time since 2023Director purchased ~$63K of GEHC shares in the open market
3. May 12, 2026Insider · 4 insiders in a week, a first since 2023Director purchased ~$100K of GEHC shares in the open market
4. May 14, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 4.6%
5. May 14, 20265% stakeDodge & Cox reported a passive stake (13G) of 6.9%
6. May 22, 2026Insider · Their first buy on recordDirector purchased ~$642K of GEHC shares in the open market
7. Jul 21, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.”
8. Jul 21, 2026FDAFDA device clearance: CardIQ Suite
9. Jul 24, 2026FDAFDA device clearance: Monitor B105M; Monitor B125M; Monitor B155M; Monitor B105P; Monitor B125P
10. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
11. Jul 30, 2026FDAFDA device clearance: LOGIQ Focus
12. Jul 30, 2026FDARecall: Carescape Central Station CSCS V3 MAS800 Desktop Part Number 5867474-04, 5867474-13 Product code STU CSCS V3 MAI800 Integrated Part Number 5867474-03 Product C…
13. Jul 31, 2026FDARecall: Centricity PACS Server V7, intended for managing digital medical images and associated data, All versions
14. Jul 31, 2026FDARecall: Centricity PACS V2, V3, V4, V6, V7, software product is intended for the storage, reading, diagnostic review, analysis, annotation, distribution, printing, edi…
15. Jul 31, 2026FDARecall: Centricity Enterprise Archive V2, V3, and V4, software product for receiving, archiving, and sending electronic medical data, All Versions
16. Jul 31, 2026FDARecall: Core Services Hub V8, a set of backend services including Cross Enterprise (XE) and Workflow Core (WFC) services that enables enterprise imaging workflows, All…
17. Jul 31, 2026FDARecall: Workflow Core Services V8, intended to provide set of services for storage and retrieval of patient data, exams and performs system Administration, common conf…
18. Jul 31, 2026FDARecall: Enterprise Archive V8, software product for receiving, archiving, and sending electronic medical data, All versions
19. Aug 7, 2026FDAFDA device clearance: Venue Go
20. Aug 7, 20265% stakeDodge & Cox reported a passive stake (13G) of 8.3%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for GE HealthCare

For GE HealthCare, OQRO holds 1 Congress trade report and 25 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GEHC page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at GE HealthCare

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its GEHC page.